Results 291 to 300 of about 3,666,403 (333)

Case Report: A severe drug-induced immune hemolytic anemia caused by vancomycin. [PDF]

open access: yesFront Med (Lausanne)
Xie Y   +7 more
europepmc   +1 more source

A validated panel of commercial antibodies for reliable detection of FET proteins

open access: yes
Tacconelli S   +8 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Computational Analysis of Antibody Paratopes for Antibody Sequences in Antibody Libraries

2022
To ensure the functionalities of the antibodies in phage-displayed synthetic antibody libraries, we use computational method to evaluate the designs of the antibody libraries. The computational methodologies developed in our lab for designing antibody library provide rich information on the function of the designed antibody sequences-adequate antibody ...
Hung-Pin, Peng, An-Suei, Yang
openaire   +2 more sources

Antibody and antibody fragments for cancer immunotherapy

Journal of Controlled Release, 2020
Antibody has become the most rapidly expanding class of pharmaceuticals for treating a wide variety of human diseases including cancers. Especially, with the fast development of cancer immunotherapy, antibody drugs have become the most promising therapeutic for curing cancers.
Weizhi Chen, Yang Yuan, Xiqun Jiang
openaire   +2 more sources

Catalytic Antibodies

Current Opinion in Chemical Biology, 1998
Following the end of the first decade in catalytic antibody research, recent efforts are reflecting a more introspective view of the field. Notably, X-ray crystal structure analyses of antibody catalysts are permitting an increased understanding of the evolution and modus operandi of these remarkable biocatalysts. Additionally, the breadth and scope of
P, Wentworth, K D, Janda
openaire   +2 more sources

Antibodies and Selection of Monoclonal Antibodies

2015
Monoclonal antibodies are universal binding molecules with a high specificity for their target and are indispensable tools in research, diagnostics and therapy. The biotechnological generation of monoclonal antibodies was enabled by the hybridoma technology published in 1975 by Köhler and Milstein.
Katja, Hanack   +2 more
openaire   +2 more sources

Phage antibodies: will new ‘coliclonal’ antibodies replace monoclonal antibodies?

Trends in Biotechnology, 1992
Antibodies can now be rapidly isolated from large and diverse recombinant libraries by displaying functional antibody fragments on the surface of bacteriophage particles and directly selecting with antigen. This method has been used to isolate antibodies, including human antibodies, with and without immunization, and to improve the affinity and ...
D J, Chiswell, J, McCafferty
openaire   +2 more sources

Monoclonal Antibodies, Bispecific Antibodies and Antibody-Drug Conjugates in Oncohematology

Recent Patents on Anti-Cancer Drug Discovery, 2020
Background: The therapeutic outcomes and the prognosis of patients with various hematologic malignancies are not always ideal with the current standard of care. Objective: The aim of this study is to analyze the results of the use of monoclonal antibodies, bispecific antibodies and antibody-drug conjugates for the therapy of malignant hemopathies.
openaire   +2 more sources

Home - About - Disclaimer - Privacy